Cargando…

Direct oral anticoagulants (DOAC) versus vitamin K antagonist in left ventricular thrombus: An updated meta‐analysis

BACKGROUND AND AIMS: Current clinical guidelines for treating left ventricular thrombus (LVT) are limited by inadequate evidence to inform the comparative efficacy of oral anticoagulants. In this meta‐analysis, we aimed to compare the efficacy and safety of direct oral anticoagulants (DOAC) to vitam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shrestha, Dhan B., Dawadi, Sagun, Dhakal, Bishal, Shtembari, Jurgen, Patel, Toralben, Shaikh, Rafae, Bodziock, George M., Shantha, Ghanshyam, Trankle, Cory R., Patel, Nimesh K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667961/ https://www.ncbi.nlm.nih.gov/pubmed/38028683 http://dx.doi.org/10.1002/hsr2.1736

Ejemplares similares

Outcome of In-Hospital Cardiac Arrest among Patients with COVID-19: A Systematic Review and Meta-Analysis
por: Shrestha, Dhan Bahadur, et al.
Publicado: (2023)

Efficacy and Safety of Pulsed Field Ablation in Atrial Fibrillation: A Systematic Review
por: Shtembari, Jurgen, et al.
Publicado: (2023)

Efficacy and Safety of Direct-Acting Oral Anticoagulants (DOACs) in the Overweight and Obese
por: Doucette, Kimberley, et al.
Publicado: (2020)

Laboratory Monitoring of Direct Oral Anticoagulants (DOACs)
por: Dunois, Claire
Publicado: (2021)

New Direct Oral Anticoagulants (DOAC) and Their Use Today
por: Schwarb, Heike, et al.
Publicado: (2016)

Spontaneous rectal sheath bleed while on DOAC anticoagulation
por: de Courcy, Louis, et al.
Publicado: (2023)

Bulbar onset amyotrophic lateral sclerosis: A case report
por: Pudasaini, Prasamsa, et al.
Publicado: (2022)

Optimization of DOAC management services in a centralized anticoagulation clinic
por: Sylvester, Katelyn W., et al.
Publicado: (2022)

New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs)
por: van Gorp, Rick H., et al.
Publicado: (2015)

Relationship of size of corpus callosum with white matter changes in elderly population; A retrospective analytical cross-sectional study
por: Shrestha, Sadina, et al.
Publicado: (2022)

Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment
por: Burnett, Allison E., et al.
Publicado: (2016)

Perioperative Management of Direct Oral Anticoagulants (DOACs): A Systemic Review
por: Sunkara, Tagore, et al.
Publicado: (2016)

Performance Characteristics of DOAC Dipstick in Determining Direct Oral Anticoagulants in Urine
por: Harenberg, Job, et al.
Publicado: (2021)

Direct Oral Anticoagulants (DOAC): Are We Ready for a Pharmacogenetic Approach?
por: Palmirotta, Raffaele
Publicado: (2021)

DOACs in the Anticoagulation of Mechanical Valves: A Systematic Review and Future Perspectives
por: Langenaeken, Tom, et al.
Publicado: (2023)

DOAC‐Stop in lupus anticoagulant testing: Direct oral anticoagulant interference removed in most samples
por: Baker, Steven Andrew, et al.
Publicado: (2021)

Drug Use Evaluation of Direct Oral Anticoagulants (DOACs) in Patients With Advanced Cirrhosis
por: Jarboe, Lindsey, et al.
Publicado: (2022)

Anticoagulation After Ischemic Stroke or Transient Ischemic Attack (TIA) in the Time of Direct Oral Anticoagulation (DOAC) and Thrombectomy
por: Martin Diaz, Claudia, et al.
Publicado: (2021)

Ciprofloxacin induced toxic epidermal necrolysis with cholestatic hepatitis: A case report with literature review and revisit to the Naranjo adverse drug reaction probability scale
por: Dhakal, Bishal, et al.
Publicado: (2022)

Novel reversal agents and laboratory evaluation for direct-acting oral anticoagulants (DOAC): An update
por: Shah, Shagun B, et al.
Publicado: (2019)

Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase(®)
por: Sessa, Maurizio, et al.
Publicado: (2019)

Drug-Drug Interactions of Direct Oral Anticoagulants (DOACs): From Pharmacological to Clinical Practice
por: Ferri, Nicola, et al.
Publicado: (2022)

Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2022)

Novel Ex Vivo DOAC Removal Methods Reduce Interference in Lupus Anticoagulant Testing
por: Savola, Paula, et al.
Publicado: (2022)

Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2022)

Upper Gastrointestinal Bleeding Induced by Gastric Ulcer Secondary to Strongyloidiasis: A Case Report
por: Dhakal, Bishal, et al.
Publicado: (2023)

Direct Oral Anticoagulant removal by a DOAC filter: Impact on lupus anticoagulant testing – Evaluation on spiked and patient samples
por: Linskens, Eleni A., et al.
Publicado: (2022)

Direct oral anticoagulants compared to vitamin K antagonist for the management of left ventricular thrombus
por: Iqbal, Hansa, et al.
Publicado: (2020)

Assessment of non‐vitamin K antagonist oral anticoagulants for the management of left ventricular thrombus
por: Li, Shunhui, et al.
Publicado: (2021)

Management of Traumatic Brain Injury in Patients with DOAC Therapy–Are the “New” Oral Anticoagulants Really Safer?
por: Antoni, Anna, et al.
Publicado: (2022)

Direct oral anticoagulant (DOAC) monitoring within primary care: a quality improvement project
por: McFadzean, Isobel Joy, et al.
Publicado: (2023)

The Effect of Direct Oral Anticoagulant Therapy (DOACs) on oral surgical procedures: a systematic review
por: Darwish, Ghassan
Publicado: (2023)

Electric Cardioversion vs. Pharmacological with or without Electric Cardioversion for Stable New-Onset Atrial Fibrillation: A Systematic Review and Meta-Analysis
por: Prasai, Paritosh, et al.
Publicado: (2023)

Evaluation of the DOAC-Stop® Procedure to Overcome the Effect of DOACs on Several Thrombophilia Screening Tests
por: Favresse, Julien, et al.
Publicado: (2018)

Uninterrupted DOACs Approach for Catheter Ablation of Atrial Fibrillation: Do DOACs Levels Matter?
por: Hardy, Michael, et al.
Publicado: (2022)

Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims data
por: Warkentin, Lisette, et al.
Publicado: (2022)

Economic evaluation of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation: a systematic review and meta-analysis
por: Noviyani, Rini, et al.
Publicado: (2022)

Retrospective Analysis of Direct-Acting Oral Anticoagulants (DOACs) Initiation Timing and Outcomes After Thrombolysis in High- and Intermediate-Risk Pulmonary Embolism
por: Wolfe, Adam, et al.
Publicado: (2023)

DOAC in COVID-19: Yes or No?
por: Schutgens, Roger E.
Publicado: (2020)

Adverse Events of DOACs in Children
por: Bosch, Alessandra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rne3s87c4lr4jga3c7osjs3p8o